[Federal Register Volume 63, Number 96 (Tuesday, May 19, 1998)]
[Notices]
[Pages 27582-27583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13410]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Open Meeting for Representatives of Health Professional 
Organizations

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting with representatives of health professional organizations. The 
meeting will be chaired by Sharon Smith Holston, Deputy Commissioner 
for External Affairs. The agenda will include presentations and 
discussions on the main topic of emerging infectious diseases. FDA 
staff will make presentations on FDA's involvement in the President's 
Food Safety Initiative, antimicrobial resistance, and issues in vaccine 
development and diagnostics. There will also be brief updates on

[[Page 27583]]

tobacco and the FDA Modernization Act.

DATES: The meeting will be held on Thursday, May 28, 1998, from 2 p.m. 
to 4 p.m.

ADDRESSES: The meeting will be held at the Bethesda Holiday Inn, 8120 
Wisconsin Ave., Bethesda, MD.

FOR FURTHER INFORMATION CONTACT: Peter H. Rheinstein, Office of Health 
Affairs (HFY-40), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6630.
Registration: There is no registration fee, however, space is limited. 
Persons will be registered in the order in which calls are received. 
Please call Betty Palsgrove at 301-827-6618 to register. Registrations 
also may be transmitted by FAX to 1-800-344-3332 or 301-443-2446. 
Please include the name and title of the person attending and the name 
of the organization.
SUPPLEMENTARY INFORMATION: The purpose of the meeting is to provide an 
opportunity for representatives of health professional organizations 
and other interested persons to be briefed by senior FDA staff. It will 
also provide an opportunity for informal discussion on these topics of 
particular interest to health professional organizations.
    This public meeting is free of charge; however, space is limited. 
Registration for the meeting will be accepted in the order received and 
should be sent to the contact person. Registration should include the 
name and title of the person attending and the name of the organization 
being represented, if any.

    Dated: May 13, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-13410 Filed 5-15-98; 2:58 pm]
BILLING CODE 4160-01-F